Osteopontin Market Share Size & Trends Analysis by Application (Infant Formula) & By Region Forecast, 2022-2032
Analysis of Osteopontin Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Osteopontin Market Outlook (2022 to 2032)
The whey protein, which comes from cow's milk and can be used in infant formula and baby nutrition diets, has undergone extensive phosphorylation. Arla Food Ingredients Company, a well-known provider of infant formulas, was the first to use it.
The widespread use of osteopontin in infant formula will likely increase consumer demand for the substance in the near future. The market for osteopontin is probably going to grow as newborn formula and baby food sales rise. The market will benefit from the expanding demand for newborns’ immunological dietary formulae.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The new age of Baby Food Formulas
Manufacturers are concentrating on releasing high-quality newborn formulae that can be tailored to a child's diseases and meet other nutritional requirements. The expansion of a variety of products and the development of new-born formulae including DHA and other significant nutritional elements do not change the product's qualities. Manufacturers of infant formula put a lot of effort into creating formulas with characteristics that are comparable to those of breast milk and that feature osteopontin as a key component.
A milk protein called osteopontin is thought to play a part in bone and tooth health as well as immune system development. The EFSA has released a scientific opinion on the safety of bovine milk osteopontin as a new product in response to a request from Arla Foods Ingredients.
The novel food is designed to be used in infant formula (IF), follow-on formula (FoF), and ready-to-eat dairy-based meals for children up to 35 months of age at a maximum use level of 151 mg/L. In comparison to the concentration naturally present in cow milk and current IF, the proposed dosage is ten times higher.
Manufacturers' main areas of attention are product quality improvement and content innovation. Doctors, doctors, and nutritionists' recommendations can affect consumers' decisions to purchase protein formulas.
The gender wage gap has been closing in recent years, while the global employment rate has been rising quickly. As per the world bank, the global labor force participation is just over 50%, and it is expected to rise in the years to come. Infants are less likely to nurse as a result, and the need for protein-based formulae containing osteopontin is growing.
Futuristic Developments in the Regions
The percentage of preterm births in the United States from 1990 to 2020 is shown in this statistic. Preterm births as a percentage of all births reached their highest level in 2006 at 12.8%. Around 10.1 percent of all births in the US occurred preterm in 2020.
A child is considered preterm if it was born before 37 weeks of gestation. Infants that are born prematurely often have anomalies such as hypoallergenic conditions, malabsorption problems, and malmetabolic diseases.
The U.S. Food and Drug Administration (FDA) has created nutrient criteria for infant formulae that all producers must adhere to under the Federal Food, Drug, and Cosmetic Act (FFDCA). The market in North America is anticipated to expand more quickly as customers increase their spending on high-end infant items.
The market for protein-based infant formula in Europe is profitable thanks to a supportive regulatory environment and growing consumer awareness of the value of nutritional intake for infants, which will help to support the demand for osteopontin in the near future. The World Health Organization (WHO) reports that China and India have the most preterm births.
Favorable government initiatives and a rise in consumer education campaigns about newborn health are fueling a boom in infant formulae with proteins, which will probably increase the Asia Pacific region's osteopontin market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
One of the top producers of food components has just recently released osteopontin. The market submitted a GRAS regulation in 2017 and received approval for continuous usage. Only one company is currently producing osteopontin on the market, and that company is Arla Foods Ingredients Group P/S.
The research report provides a thorough analysis of the market and is filled with insightful observations, relevant data, historical information, and market statistics that have been verified by the relevant industries. Additionally, it contains estimates for the market made using a relevant set of assumptions and methodology. The research report offers analysis and data according to market segments like regions, product types, natures, and applications.
Osteopontin Market Segmentation :
Currently, osteopontin is being manufactured by a prominent ingredient company with food-grade purity of a minimum of 95% and its only application is ie infant formula. Further research and development of this protein may envision a new set of applications and end-use of the protein.
Based on regions, the market is segmented into :
- Asia Pacific
- Rest of the World
- FAQs -
The North American market is likely to gain a major share of this market.
Rising infant disorders and advancement in formula aids in a rise in Osteopontin for nutritional needs.
Improvement in the overall quality of products and innovation in the content are the key focus areas of manufacturers.
A favourable regulatory framework and increasing consumer awareness about the importance of nutritional intake for babies are making growth in the European markets.